Thursday, March 29, 2012

FDA Adds Warnings to Statin Label

A factor contributing to the "need" for a statin is fatosity.
Taking a statin can raise blood sugar and glycosylated hemoglobin HbA1c levels, according to a new labeling change approved by the Food and Drug Administration (FDA) today for the entire drug class.
Better to lose the weight than "need" the drug.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.